Free Annual ReportsNovartis Shs Sponsored American Deposit Receipt Repr 1 Sh $ 76.70
+1.50
Digital Company Profile
| Last Trade: | 76.70 |
| Trade Time: | Sep 18 06:40 PM Eastern Daylight Time |
| Change: | 1.50 (2.00 %) |
| Prev Close: | 75.20 |
| Open: | 75.42 |
| Bid: | 76.72 |
| Ask: | 76.73 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get NVS Trend Analysis
-
it has outperformed the S&P 500 by 9%
ETF Alternatives
| Ticker | Name | Weight | % Change |
|---|---|---|---|
| PPH | Market Vectors Pharmaceutical ETF | 7.48% | +1.02% |
| ADRU | BLDRS Europe 100 ADR Index | 5.84% | +2.23% |
| ADRD | BLDRS Developed Markets 100 ADR Index | 4.77% | +3.09% |
| RRGR | AdvisorShares Global Alpha & Beta ETF | 3.45% | +2.16% |
| NYC | iShares NYSE Composite | 1.02% | +1.62% |
Competitors
| Ticker | Name | Volume | % Change |
|---|---|---|---|
| PFE | Pfizer Inc | 30.22M | +1.40% |
| MRK | Merck & Co Inc | 14.01M | +0.81% |
| BMY | Bristol Myers Squibb Co | 10.39M | +2.47% |
| JNJ | Johnson & Johnson | 10.09M | +0.95% |
| ELTP | Elite Pharmaceuticals Inc | 9.90M | +21.50% |
NVS Stock Analysis
-
Free Managed Futures Book
Get the four benefits of managed futures as outlined in this booklet. -
View the Portfolios of the Worlds Top Investors, FREE!
Learn from Warren Buffett, George Soros and More! -
7 Proven Strategies for Market-Stomping Stocks
Discover Investing Strategies that will Benefit Every Investor Today!
Free Annual Reports